XML 118 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Share-Based Payments (Tables)
3 Months Ended
Mar. 31, 2020
Share-based Payment Arrangement [Abstract]  
Share-based compensation expense included in condensed consolidated statements of income
The following table summarizes share-based compensation expense included in our condensed consolidated statements of income:
 
For the Three Months
Ended March 31,
(In millions)
2020
 
2019
Research and development
$
33.3

 
$
21.7

Selling, general and administrative
43.1

 
27.8

Subtotal
76.4

 
49.5

Capitalized share-based compensation costs
(1.5
)
 
(3.3
)
Share-based compensation expense included in total cost and expenses
74.9

 
46.2

Income tax effect
(13.3
)
 
(7.4
)
Share-based compensation expense included in net income attributable to Biogen Inc.
$
61.6

 
$
38.8


Summary of share-based compensation expense associated with each of our share-based compensating programs
The following table summarizes share-based compensation expense associated with each of our share-based compensation programs:
 
For the Three Months
Ended March 31,
(In millions)
2020
 
2019
Market stock units
$
19.1

 
$
7.7

Time-vested restricted stock units
37.5

 
34.7

Cash settled performance units
(1.6
)
 
(1.0
)
Performance units
(0.1
)
 
0.5

Performance stock units settled in stock
10.3

 
2.0

Performance stock units settled in cash
8.9

 
1.0

Employee stock purchase plan
2.3

 
4.6

Subtotal
76.4

 
49.5

Capitalized share-based compensation costs
(1.5
)
 
(3.3
)
Share-based compensation expense included in total cost and expenses
$
74.9

 
$
46.2